Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Loomba

Showing results (571-580 of 636) with videos related to

Pageof 64
Sort By:
Alimentary Pharmacology & Therapeutics|October 28, 2024
Prevalence of Low FIB-4 in MASLD-Related Hepatocellular Carcinoma: A Multicentre StudyDarren Jun Hao Tan, Nobuharu Tamaki, Beom Kyung Kim, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 10, 2025
The Global Burden of Cirrhosis and Other Chronic Liver Diseases in 2021Ethan Kai Jun Tham, Darren Jun Hao Tan, Pojsakorn Danpanichkul, et al.
Journal of Clinical and Experimental Hepatology|July 13, 2023
Hepatic, Extra-hepatic Outcomes and Causes of Mortality in NAFLD - An Umbrella Overview of Systematic Review of Meta-AnalysisJieling Xiao, Cheng Han Ng, Kai En Chan, et al.
The Journal of Clinical Investigation|November 1, 2022
Risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fatty liver diseaseNobuharu Tamaki, Noora Ahlholm, Panu K Luukkonen, et al.
Hepatology (Baltimore, Md.)|March 25, 2022
Reliability of histologic assessment for NAFLD and development of an expanded NAFLD activity scoreRish K Pai, Vipul Jairath, Malcolm Hogan, et al.
Hepatology (Baltimore, Md.)|August 24, 2017
A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosisScott L Friedman, Vlad Ratziu, Stephen A Harrison, et al.
Clinical and Molecular Hepatology|October 20, 2022
Global prevalence of depression and anxiety in patients with hepatocellular carcinoma: Systematic review and meta-analysisDarren Jun Hao Tan, Sabrina Xin Zi Quek, Jie Ning Yong, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 16, 2018
Hepatic R2* is more strongly associated with proton density fat fraction than histologic liver iron scores in patients with nonalcoholic fatty liver diseaseMustafa R Bashir, Tanya Wolfson, Anthony C Gamst, et al.
Nature|July 6, 2018
Author Correction: Inflammation-induced IgA<sup>+</sup> cells dismantle anti-liver cancer immunityShabnam Shalapour, Xue-Jia Lin, Ingmar N Bastian, et al.
Alimentary Pharmacology & Therapeutics|April 24, 2023
Meta-analysis: Prevalence of significant or advanced fibrosis in adults with alpha-1-antitrypsin deficiencyDaniel Q Huang, Kai En Chan, Caitlyn Tan, et al.
Pageof 64

Showing results (571-580 of 636) with videos related to

Sort By:
Pageof 64
Alimentary Pharmacology & Therapeutics|October 28, 2024
Prevalence of Low FIB-4 in MASLD-Related Hepatocellular Carcinoma: A Multicentre StudyDarren Jun Hao Tan, Nobuharu Tamaki, Beom Kyung Kim, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 10, 2025
The Global Burden of Cirrhosis and Other Chronic Liver Diseases in 2021Ethan Kai Jun Tham, Darren Jun Hao Tan, Pojsakorn Danpanichkul, et al.
Journal of Clinical and Experimental Hepatology|July 13, 2023
Hepatic, Extra-hepatic Outcomes and Causes of Mortality in NAFLD - An Umbrella Overview of Systematic Review of Meta-AnalysisJieling Xiao, Cheng Han Ng, Kai En Chan, et al.
The Journal of Clinical Investigation|November 1, 2022
Risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fatty liver diseaseNobuharu Tamaki, Noora Ahlholm, Panu K Luukkonen, et al.
Hepatology (Baltimore, Md.)|March 25, 2022
Reliability of histologic assessment for NAFLD and development of an expanded NAFLD activity scoreRish K Pai, Vipul Jairath, Malcolm Hogan, et al.
Hepatology (Baltimore, Md.)|August 24, 2017
A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosisScott L Friedman, Vlad Ratziu, Stephen A Harrison, et al.
Clinical and Molecular Hepatology|October 20, 2022
Global prevalence of depression and anxiety in patients with hepatocellular carcinoma: Systematic review and meta-analysisDarren Jun Hao Tan, Sabrina Xin Zi Quek, Jie Ning Yong, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 16, 2018
Hepatic R2* is more strongly associated with proton density fat fraction than histologic liver iron scores in patients with nonalcoholic fatty liver diseaseMustafa R Bashir, Tanya Wolfson, Anthony C Gamst, et al.
Nature|July 6, 2018
Author Correction: Inflammation-induced IgA<sup>+</sup> cells dismantle anti-liver cancer immunityShabnam Shalapour, Xue-Jia Lin, Ingmar N Bastian, et al.
Alimentary Pharmacology & Therapeutics|April 24, 2023
Meta-analysis: Prevalence of significant or advanced fibrosis in adults with alpha-1-antitrypsin deficiencyDaniel Q Huang, Kai En Chan, Caitlyn Tan, et al.
Pageof 64